Taiwan Liposome Company (TLC) is a biopharmaceutical company focused on the research, development and commercialization of innovative pharmaceutical products based on its proprietary drug delivery technologies. Our strengths lie in lipid-based formulation and scale-up for parenteral drugs using micelles and nanoparticles to optimize the pharmacokinetics of drugs for better efficacy and lower toxicity, and thus prolong the product lifecycle of branded drugs.

Vision
TLC is dedicated to maximizing the benefits of medications for patients and improving their quality of life through constantly advancing our technology & know-how.

Mission
TLC strives to become a global leading biopharmaceutical company, to contribute more towards making a difference in the healthcare industry and make Taiwan biotechnology industry visible in the global arena.